Kaleido Biosciences (KLDO) Financial Statements

Kaleido Biosciences's market cap is currently $4.26K. The company's EPS TTM is $; its P/E ratio is ―; Kaleido Biosciences is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.